title: [Current status of clinical trials of novel agents for multiple myeloma].
authors.forename: Junya
authors.initials: J
authors.lastname: Kuroda
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D017277:Drug Approval; D055808:Drug Discovery / Q000639:trends*; D056572:Histone Deacetylase Inhibitors / Q000008:administration & dosage; D006801:Humans; D006877:Hydroxamic Acids / Q000008:administration & dosage; D007783:Lactones / Q000008:administration & dosage; D058990:Molecular Targeted Therapy; D009101:Multiple Myeloma / Q000188:drug therapy*; D009842:Oligopeptides / Q000008:administration & dosage; D011758:Pyrroles / Q000008:administration & dosage; D013792:Thalidomide / Q000008:administration & dosage / Q000031:analogs & derivatives; D000077337:Vorinostat
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D056572:Histone Deacetylase Inhibitors; D006877:Hydroxamic Acids; D007783:Lactones; D009842:Oligopeptides; D011758:Pyrroles; C546027:elotuzumab; D013792:Thalidomide; D000077337:Vorinostat; C475865:marizomib; C524865:carfilzomib; C467566:pomalidomide